Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

When President Donald Trump wanted to make the case for his first term’s success in an interview last month, he turned to the stock market. “I was very proud to have handed over the country ...

NEW YORK (Reuters) -U.S. stocks fell on Tuesday, adding to the biggest selloff in months, as investors worried about the impact of the latest tariff threats on the global economy. Trading was ...

Nigeria's Economic and Financial Crimes Commission (EFCC) has reported a landmark recovery of nearly $500 million in proceeds of crime in the past year, alongside securing over 4,000 criminal ...

Three local genetic correlation (LGC) genomic prediction methods are proposed to incorporate LGCs into multi-trait genomic prediction and could universally improve prediction accuracy compared to ...

Tesco has launched a new trial where it is weighing trolleys at the till. The supermarket giant has introduced giant trolley scales at a branch in Gateshead. These are used to weigh trolleys ahead of ...

marking a major attack on worker rights under the Trump administration. Related Articles National Politics | Judge calls Trump administration’s latest response on deportation flights ‘woefully ...

Fabian extended Auburn’s lead back to two with a solo homer in the bottom of the sixth, marking his third long ball of the season. The Tigers threatened for more in the frame but left the bases ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

AbbVie said on Monday that it will pay up to $2.2 billion to develop Danish drugmaker Gubra's experimental obesity drug, marking its late ... I'm here on the ground at the 2025 HIMSS Global ...